Seale et al. recently described a case of refractory flat warts in a patient with atopic dermatitis shortly after initiating upadacitinib therapy, suggesting that JAK1 blockade may exacerbate HPV-driven cutaneous lesions [11]. The gene discussed is JAK1; the disease is atopic eczema.